Alembic Pharma gains after receiving US FDA nod for psoriasis treatment drug Acitretin

Alembic Pharmaceuticals advanced 2.67% to Rs 1216.10 after the company received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Acitretin Capsules.